攻癌镇痛散外敷治疗癌性疼痛临床研究
|
摘要
目的:观察攻癌镇痛散外敷治疗癌性疼痛的临床疗效。方法:100例随机分为治疗组和对照组各50例,两组均用三阶梯药物镇痛治疗,治疗组在疼痛处增加攻癌镇痛散外敷,两组疗程均为10天。结果:治疗组疗效优于对照组(P<0.05)。结论:三阶梯药物镇痛治疗的基础上加用攻癌镇痛散外敷,可提高癌症患者生存质量,减少镇痛药物的不良反应。
Objective:To observe the clinical efficacy of external application of Gong'ai Zhentong Powder in the treatment of cancer pain. Method: 100 cases were evenly divided into the combination therapy group and the control group in random. Both groups were treated with three-step drug analgesia. The treatment group treated with the external application of Gong'ai Zhentong Powder at the painful place. The course of treatment was 10 days. Result: The curative effect of the treatment group were superior to that of the control group(P<0.05). Conclusion: On the basis of the three-step drug analgesic treatment, external application of Gong'ai Zhentong Powder on painful place could enhance the life quality ofthe cancer patients and decrease the adverse reactions of analgesic drugs.
Objective:To observe the clinical efficacy of external application of Gong'ai Zhentong Powder in the treatment of cancer pain. Method: 100 cases were evenly divided into the combination therapy group and the control group in random. Both groups were treated with three-step drug analgesia. The treatment group treated with the external application of Gong'ai Zhentong Powder at the painful place. The course of treatment was 10 days. Result: The curative effect of the treatment group were superior to that of the control group(P<0.05). Conclusion: On the basis of the three-step drug analgesic treatment, external application of Gong'ai Zhentong Powder on painful place could enhance the life quality ofthe cancer patients and decrease the adverse reactions of analgesic drugs.
引文
[1]王妙苗.癌痛的发生机制及其相关药物治疗的研究现状[J].临床肿瘤学杂志,2011,16(7):662-666.
[2]武林鑫,孙莉.癌痛治疗不足的现状与原因[J].肿瘤防治研究,2014,41(4):421-424.
[3]高万露,汪小海.患者疼痛评分法的术前选择及术后疼痛评估的效果分析[J].实用医学杂志,2013,29(23):3892-3894.
[4]李春蕊,张雯,樊碧发.数字评分法(NRS)与口述评分法(VRS)在老年慢性疼痛患者中的比较[J].中国疼痛医学杂志,2016,22(9):683-686.
[5]刘敏,张璐,孙丽华,等.辽宁省肿瘤化疗患者KPS评分情况分析[J].中国肿瘤,2013,22(8):635-637.
[6]梁永新,褚海辰.P2X受体在癌痛机制中的作用[J].现代肿瘤医学,2016,24(11):1841-1844.
[7]王洪波.疼痛专科护理对恶性肿瘤癌痛患者生存质量的影响[J].社区医学杂志,2016(5):78-80.
[8]张磊,李换男,杨岚.中医治疗癌性疼痛研究进展[J].云南中医中药杂志,2016,37(8):86-88.
[9]赵志正,刘杰,林洪生.中医药治疗癌性疼痛研究进展[J].世界中医药,2014(7):851-856.
[10]巫桁锞,熊慧生,文军.攻癌镇痛散外敷治疗癌性疼痛临床观察[J].中国中医急症,2012,21(7):1128-1129.
[2]武林鑫,孙莉.癌痛治疗不足的现状与原因[J].肿瘤防治研究,2014,41(4):421-424.
[3]高万露,汪小海.患者疼痛评分法的术前选择及术后疼痛评估的效果分析[J].实用医学杂志,2013,29(23):3892-3894.
[4]李春蕊,张雯,樊碧发.数字评分法(NRS)与口述评分法(VRS)在老年慢性疼痛患者中的比较[J].中国疼痛医学杂志,2016,22(9):683-686.
[5]刘敏,张璐,孙丽华,等.辽宁省肿瘤化疗患者KPS评分情况分析[J].中国肿瘤,2013,22(8):635-637.
[6]梁永新,褚海辰.P2X受体在癌痛机制中的作用[J].现代肿瘤医学,2016,24(11):1841-1844.
[7]王洪波.疼痛专科护理对恶性肿瘤癌痛患者生存质量的影响[J].社区医学杂志,2016(5):78-80.
[8]张磊,李换男,杨岚.中医治疗癌性疼痛研究进展[J].云南中医中药杂志,2016,37(8):86-88.
[9]赵志正,刘杰,林洪生.中医药治疗癌性疼痛研究进展[J].世界中医药,2014(7):851-856.
[10]巫桁锞,熊慧生,文军.攻癌镇痛散外敷治疗癌性疼痛临床观察[J].中国中医急症,2012,21(7):1128-1129.